The decline in human African trypanosomiasis cases can be attributed to significant advancements in diagnosis and treatment, particularly the shift to less toxic and more effective medications. Collaborative efforts under national sleeping sickness control programs and the leadership of organizations like WHO have been crucial in this progress, highlighting the importance of joint initiatives and training at the country level.
